文献速递糖尿病肥胖与代谢综合征

保留比值受损肺功能、代谢组学与2型糖尿病风险

Preserved Ratio Impaired Spirometry, Metabolomics, and the Risk of Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

基于英国生物银行72 683名基线无糖尿病者,中位随访12.06年,PRISm组较正常肺功能组2型糖尿病风险增加47%(95%CI 33%-63%),121种循环代谢物介导该关联,前5种代谢标志物中介比例最高达11.91%。

要点

  • PRISm与2型糖尿病风险增加相关,风险比升高47%(95%CI 33%-63%)。
  • 121种循环代谢物对PRISm与2型糖尿病关联有显著中介效应(FDR<0.05)。
  • 11个主成分解释代谢特征95%方差,中介比例为25.47%(95%CI 20.83%-32.19%)。

核心结论

  • PRISm与2型糖尿病风险相关,循环代谢物可能在该关联中起中介作用。

研究设计与样本

  • 研究使用英国生物银行数据,纳入基线无糖尿病的72 683人。
  • PRISm定义为预测FEV1<80%且FEV1/用力肺活量比值≥0.70。
  • 采用Cox比例风险模型评估基线PRISm与新发2型糖尿病的纵向关系,并用中介分析探讨循环代谢物的中介效应。

主要发现

  • 中位随访12.06年期间,2513人发生2型糖尿病。
  • PRISm组(N=8394)较正常肺功能组(N=64 289)发生2型糖尿病的风险增加47%(95%CI 33%-63%)。
  • 121种代谢物在PRISm至2型糖尿病路径中显示统计学显著中介效应(FDR<0.05)。
  • 中介比例前5的代谢标志物:糖蛋白乙酰类11.91%(95%CI 8.76%-16.58%)、大颗粒高密度脂蛋白中的胆固醇酯11.04%(95%CI 7.34%-15.55%)、不饱和度10.36%(95%CI 7.34%-14.71%)、大颗粒高密度脂蛋白中的胆固醇9.87%(95%CI 6.78%-14.09%)、极大颗粒高密度脂蛋白中的胆固醇酯9.51%(95%CI 6.33%-14.05%)。
  • 解释代谢特征95%方差的11个主成分中介了PRISm与2型糖尿病关联的25.47%(95%CI 20.83%-32.19%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Whether baseline preserved ratio impaired spirometry (PRISm) is associated with the risk of developing type 2 diabetes (T2D) and if this association could be mediated by circulating metabolites remains to be elucidated. OBJECTIVE: To measure the prospective association of PRISm with T2D and potential metabolic mediators thereof. METHODS: This study used data from the UK Biobank and included 72 683 individuals without diabetes at baseline. PRISm was defined as the predicted forced expiratory volume in 1 second (FEV1) <80% and the FEV1/forced vital capacity ratio ≥0.70. Cox proportional hazards modeling was performed to assess the longitudinal relation between baseline PRISm and incident T2D. Mediation analysis was used to explore the mediation effects of circulating metabolites in the path from PRISm to T2D. RESULTS: During a median follow-up of 12.06 years, 2513 participants developed T2D. Individuals who had PRISm (N = 8394) were 47% (95% CI, 33%-63%) more likely to develop T2D compared with those who had normal spirometry (N = 64 289). A total of 121 metabolites showed statistically significant mediation effects in the path from PRISm to T2D (false discovery rate <0.05). Glycoprotein acetyls, cholesteryl esters in large high-density lipoprotein (HDL), degree of unsaturation, cholesterol in large HDL, and cholesteryl esters in very large HDL were the top 5 metabolic markers, with mediation proportions (95% CI) being 11.91% (8.76%-16.58%), 11.04% (7.34%-15.55%), 10.36% (7.34%-14.71%), 9.87% (6.78%-14.09%), and 9.51% (6.33%-14.05%), respectively. A total of 11 principal components that explained 95% variance of the metabolic signatures accounted for 25.47% (20.83%-32.19%) of the relation between PRISm and T2D. CONCLUSIONS: Our study revealed the association of PRISm with T2D risk and the potential roles of circulating metabolites in mediating this association.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li G, Jankowich MD, Lu Y, et al. Preserved Ratio Impaired Spirometry, Metabolomics, and the Risk of Type 2 Diabetes. J Clin Endocrinol Metab. 2023. PMID: 36897159. doi:10.1210/clinem/dgad140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。